Pancreatic glucagonoma presenting as a pulmonary mass.

Abstract

Glucagonoma is an uncommon disease, a neuroendocrine tumour that develops from glucagon-producing pancreatic cells. They are usually slow-growing, but generally advanced at diagnosis, and metastatic disease is virtually incurable. Liver is the most common site of metastatic disease. We present the case of a 48-year-old man with a glucagonoma being diagnosed from a pulmonary mass. This case had no liver affection in the whole evolution of the disease, and showed a particularly aggressive course, with very little response to all therapies administered, and a survival from diagnosis of just 16 months.

• Authors: A Pinto Marín, E Hernández Agudo, J Feliú, M González Barón
• Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (Clin Transl Oncol) Vol. 11 Issue 1 Pg. 60-2 (Jan 2009) ISSN: 1699-048X [Print] Italy
• PMID: 19155206 (Publication Type: Case Reports, Journal Article)

Topics

• Antineoplastic Combined Chemotherapy Protocols (therapeutic use)
• Diagnosis, Differential
• Fatal Outcome
• Glucagonoma (physiopathology, secondary, therapy)
• Humans
• Lung Neoplasms (secondary, therapy)
• Male
• Middle Aged
• Pancreatic Neoplasms (pathology, physiopathology, therapy)
• Tomography, X-Ray Computed